ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

H.H.C. Group Awarded Multi-State Approvals to Conduct Independent Medical Reviews, Delivering Critical Value to Payors

ROCKVILLE, Md., May 06, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), a leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review solutions, announces that it has been re-approved by multiple states in which it currently conducts Independent Medical Reviews (IMRs), typically for disputes regarding coverage by payors based on medical treatment necessity or appropriateness. These state designations reinforce H.H.C.’s position as a URAC-accredited Independent Review Organization (IRO) and highlights the company’s vital role in helping payors resolve claim disputes efficiently, compliantly and with clinical precision.

“Acceptance by 32 states positions us as a trusted partner from coast-to-coast,” says Bruce D. Roffé, president and CEO, H.H.C. Group. “In most states, once a coverage denial occurs, insurers must refer the case to the state, which assigns it to an approved IRO. In others, insurers can contract directly with an IRO like H.H.C.—and we are fully equipped to support both pathways. Additionally, numerous insurers have H.H.C. help them determine if they should cover a treatment requested by a plan enrollee.”

H.H.C. Group’s peer review panel includes board-certified physicians and healthcare professionals across 84 specialties and subspecialties, ensuring every review is grounded in appropriate clinical expertise. As a URAC-accredited IRO, H.H.C. upholds the highest standards for reviewer credentials, timeliness, and impartiality—essential in today’s highly regulated environment.

“With regulatory scrutiny growing and medical necessity and appropriateness determinations under increased pressure, H.H.C. Group’s IMR capabilities offer payors a trusted way to uphold clinical integrity, meet compliance demands, and avoid unnecessary litigation,” continues Roffe. “This isn’t just about regulatory approval—it’s about helping our clients fairly and effectively meet the needs of plan enrollees. We provide payors with a partner that delivers clarity, compliance and clinical credibility when it matters most.”

H.H.C. Group IMRs offer several benefits, including protecting patients, improving internal review processes, and potentially reducing litigation. They also play a crucial role in ensuring compliance with healthcare standards and can help payors streamline their processes by optimizing resource utilization and decision-making. 

About H.H.C. Group  
Dedicated to significantly reducing medical claims costs through claim negotiation, repricing and independent medical review, H.H.C. Group is a national healthcare cost-containment leader serving self-funded healthcare payors, TPAS, stop-loss carriers/captives, unions and insurers. Serving the Group Health, Workers Compensation and Auto-Health markets, H.H.C. Group delivers timely, customizable solutions and proven savings. Committed to integrity and compliance, URAC-accredited H.H.C. Group stands out as a trusted partner for reducing healthcare costs and ensuring quality outcomes.

Media:  
Brittany Tedesco
CPR Marketing
btedesco@cpronline.com  
201-641-1911x14


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.